Depression with psychomotor retardation: Diagnostic challenges and the use of psychostimulants

Journal of Palliative Medicine

Volumn 4, Issue 1, 2001, Pages 15-21

  Pereira, J ^a   Bruera, E ^b  

^a FOOTHILLS HOSPITAL   (Canada)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; METHYLPHENIDATE; PSYCHOSTIMULANT AGENT;

AGED; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMORBIDITY; DEPRESSION; DIAGNOSTIC APPROACH ROUTE; DRUG EFFECT; HUMAN; LIFE EXPECTANCY; MALE; MOOD; PALLIATIVE THERAPY; PANCREAS CANCER; PATIENT CARE; PSYCHOMOTOR RETARDATION; SELF REPORT; SIDE EFFECT;

AGED; CENTRAL NERVOUS SYSTEM STIMULANTS; DEPRESSION; HUMANS; MALE; METHYLPHENIDATE; PALLIATIVE CARE; PANCREATIC NEOPLASMS; PSYCHOMOTOR DISORDERS;

EID: 0035074796     PISSN: 10966218     EISSN: None     Source Type: Journal    
DOI: 10.1089/109662101300051906     Document Type: Article

References (52)

1. Neuropsychiatric syndromes and psychological symptoms in patients with advanced cancer
2. Psychiatric emergencies in terminally ill cancer patients
3. Depression in patients with pancreatic carcinoma. Diagnostic and treatment issues
4. Pscyho-oncology: Depression, anxiety, delirium
5. Depression and the cancer patient
6. Pemoline: An alternative psychostimulant for the management of depressive disorders in cancer patients
7. Methylphenidate treatment of patients with head and neck cancer
8. Dextroamphetamine as a treatment for depression and low energy in AIDS patients: A pilot study
9. Psychostimulants for depression in hospitalized cancer patients
10. The Edmonton symptom assessment system (ESAS): A simple method for the assessment of palliative care patients
11. Psychiatric aspects of palliative care
12. Depression in patients with cancer
13. Measurement of depression in patients with cancer
14. Depression in hospitalized cancer patients
15. Depression
16. Depression in patients with cancer
17. Diagnostic assessment of depression in the medically ill
18. Prevalence of depression in the terminally ill: Effects of diagnostic criteria and symptom threshold judgments
19. Diagnosis of major depression in cancer patients according to four sets of criteria
20. Psychopathology of pancreatic cancer: A psychobiologic probe
21. From sadness to major depression: Assessment and management in patients with cancer
22. Introduction: Psychiatric disorders in patients with progressive medical disease: The importance of diagnosis
23. Variability in the application of contemporary diagnostic criteria: Endogenous depression as an example
24. Comparative psychological disturbance in pancreatic and gastric cancer
25. Initial mental disorders in carcinoma of pancreas and stomach
26. Mental symptoms as an aid in the early diagnosis of carcinoma of the pancreas
27. Suicide in cancer patients
28. "Are you depressed?" Screening for depression in the terminally ill
29. Severe opioid toxicity and somatization of psychological distress in a cancer patient with a background of chemical dependence
30. Case report: Methylphenidate for the management of somatization in terminal cancer patients
31. Use of psychostimulants in medically ill depressed patients
32. Methylphenidate for depressive disorders in cancer patients
33. Long-term methylphenidate use in the medically ill patient with organic mood syndrome
34. Double-blind evaluation of the effects of mazindol on pain, depression, anxiety, appetite and activity in terminal cancer patients
35. Effects of methylphenidate in HIV-related depression: A comparative trial with desipramine
36. Use of stimulants in the medically ill
37. Methylphenidate
38. The use of methylphenidate in patients with incident pain receiving regular opiates. A preliminary report
39. Neuropsychological effects of methylphenidate in patients receiving a continuous infusion of narcotics for cancer pain
40. Potentiation of opioid analgesia by psychostimulant drugs: A review
41. The cancer patient with pain: Psychiatric complications and their management
42. Methylphenidate associated with narcotics for the treatment of cancer pain
43. Cognitive impairment due to AIDS related complex and its response to psychostimulants
44. The use of psychostimulants in general psychiatry: A reconsideration
45. Drug-induced depression
46. The uses of psychotropics in symptom management in advanced cancer
47. Pemoline associated hepatic injury
48. A prospective multi-center assessment of the Edmonton Staging System for cancer pain
49. Cancer pain and suicide
50. Pain and depression in patients with newly diagnosed pancreas cancer